Research Article

The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules

Table 1

Clinical characteristics of the LC patients and controls.

ParametersLC ()BLD ()HC () value

Age (year)
 Range28-8235-8728-87
 Mean (SD)58.8 (9.9)57.9 (10.6)52.3 (11.2)0.364
Gender
 Male141 (73.1)84 (71.2)97 (71.9)0.933
 Female52 (26.9)34 (28.8)38 (281)
Smoking, (%)
 Ever/current128 (66.3)72 (61.0)73 (54.1)0.081
 Never65 (33.7)46 (39.0)62 (45.9)
7-AABs, (%)
 Positive122 (63.2)20 (16.9)14 (10.4)<0.0001
 Negative71 (36.8)98 (83.1)121 (89.6)
Cancer stage, (%)Diseases ()
 I32 (16.6)Bronchitis (26)
 II45 (23.3)CAP (55)
 III47 (24.4)COPD (8)
 IV69 (35.7)Bronchiectasis (12)
Cancer subtype, (%)Pulmonary tuberculosis (6)
 Adenocarcinoma112 (58.0)Parapneumonic effusion (4)
 Squamous cell carcinoma39 (20.3)OSAS (4)
 Large cell lung carcinoma2 (1.0)CVA (3)
 SCLC40 (20.7)

HC = health controls; LC = lung cancer; BLD = benign lung diseases; SD = standard deviation; SCLC = small cell lung cancer; COPD = chronic obstructive pulmonary disease; CAP = community-acquired pneumonia; CVA = cough-variant asthma; OSAHS = obstructive sleep apnea syndrome. Compared to HC, >0.05.